Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2200336-20-3
2. Onradivir [inn]
3. Cze6g5g466
4. (2s,3s)-3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo(2.2.2)octane-2-carboxylic Acid
5. (2s,3s)-3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)-4-pyrimidinyl)amino)bicyclo(2.2.2)octane-2-carboxylic Acid
6. Bicyclo(2.2.2)octane-2-carboxylic Acid, 3-((6-cyclopropyl-5-fluoro-2-(5-fluoro-1h-pyrazolo(3,4-b)pyridin-3-yl)-4-pyrimidinyl)amino)-, (2s,3s)-
7. Refchem:168306
8. Unii-cze6g5g466
9. Chembl5095075
10. Schembl21128398
11. Glxc-26953
12. Ex-a12514
13. (2s,3s)-3-[[6-cyclopropyl-5-fluoro-2-(5-fluoro-2h-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic Acid
14. Da-66347
15. Hy-145586
16. Cs-0376485
| Molecular Weight | 440.4 g/mol |
|---|---|
| Molecular Formula | C22H22F2N6O2 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 117 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 721 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
74
PharmaCompass offers a list of Onradivir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Onradivir manufacturer or Onradivir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Onradivir manufacturer or Onradivir supplier.
A Onradivir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Onradivir, including repackagers and relabelers. The FDA regulates Onradivir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Onradivir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Onradivir supplier is an individual or a company that provides Onradivir active pharmaceutical ingredient (API) or Onradivir finished formulations upon request. The Onradivir suppliers may include Onradivir API manufacturers, exporters, distributors and traders.
Onradivir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Onradivir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Onradivir GMP manufacturer or Onradivir GMP API supplier for your needs.
A Onradivir CoA (Certificate of Analysis) is a formal document that attests to Onradivir's compliance with Onradivir specifications and serves as a tool for batch-level quality control.
Onradivir CoA mostly includes findings from lab analyses of a specific batch. For each Onradivir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Onradivir may be tested according to a variety of international standards, such as European Pharmacopoeia (Onradivir EP), Onradivir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Onradivir USP).
